Literature DB >> 15709802

Correlation of Candida species and symptoms among patients with vulvovaginal candidiasis in Maringá, Paraná, Brazil.

Márcia Edilaine Lopes Consolaro1, Thâmara Aline Albertoni, Celina Shizue Yoshida, Josmar Mazucheli, Rosane Marina Peralta, Terezinha Inez Estivalet Svidzinski.   

Abstract

Vulvovaginal candidiasis (VVC) is an infection caused by abnormal yeast growth in the mucosa of the female genital tract which is commonly diagnosed in gynecology. The aim of this study was to correlate the frequency of yeasts and their respective species in asymptomatic women with different clinical manifestation of VVC; evaluate possible relationships between number of fungus colonies and symptoms in this pathology. All patients who visited the laboratory within a period of five months, for routine examinations of vaginal secretion, independent of the presence or absence of symptoms of VVC were included in this study. Of these, women with immunodeficiency or with an infection of the genital tract by another agent were excluded. Candida albicans was the most frequently yeast isolated (60%). Among non-C. albicans yeasts, 61.5% were isolated of the asymptomatic women, 38.7% from patients with VVC and 11.1% of those from patients with RVVC. C. albicans was associated with symptoms of VVC and while, the presence of non-C. albicans yeasts with asymptomatic women. However, there was no association between the number of fungal colonies and symptoms.

Entities:  

Mesh:

Year:  2004        PMID: 15709802

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  16 in total

1.  A simplified technique for evaluating the adherence of yeasts to human vaginal epithelial cells.

Authors:  Mary Mayumi Taguti Irie; Márcia Edilaine Lopes Consolaro; Terezinha Aparecida Guedes; Lucélia Donatti; Eliana Valéria Patussi; Terezinha Inez Estivalet Svidzinski
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans.

Authors:  M E L Consolaro; T A Albertoni; A E Svidzinski; R M Peralta; T I E Svidzinski
Journal:  Mycopathologia       Date:  2005-06       Impact factor: 2.574

3.  Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence.

Authors:  Rodrigo M Rocha; Pâmela C M Delvas Zanni; Patrícia de Souza Bonfim-Mendonça; Fabrícia Gimenes; Silvia S Dantas Alczuk; Terezinha I Estivalet Svidzinski; Márcia E Lopes Consolaro
Journal:  Int Urogynecol J       Date:  2015-11-13       Impact factor: 2.894

4.  Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences.

Authors:  Armando Herrera-Arellano; Edgar O López-Villegas; Aida V Rodríguez-Tovar; Alejandro Zamilpa; Enrique Jiménez-Ferrer; Jaime Tortoriello; M Angeles Martínez-Rivera
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-04-12

5.  Effect of pepstatin A on the virulence factors of Candida albicans strains isolated from vaginal environment of patients in three different clinical conditions.

Authors:  M E L Consolaro; A Gasparetto; T I E Svidzinski; R M Peralta
Journal:  Mycopathologia       Date:  2006-08       Impact factor: 3.785

6.  In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.

Authors:  Edílson Damke; Joyce K Tsuzuki; Diógenes A G Cortez; Izabel C P Ferreira; Thâmara A Bertoni; Márcia R Batista; Lucélia Donati; Terezinha I E Svidzinski; Márcia E L Consolaro
Journal:  BMC Complement Altern Med       Date:  2011-05-04       Impact factor: 3.659

7.  Antifungal Activity of Brazilian Propolis Microparticles against Yeasts Isolated from Vulvovaginal Candidiasis.

Authors:  Kelen Fátima Dalben Dota; Marcia Edilaine Lopes Consolaro; Terezinha Inez Estivalet Svidzinski; Marcos Luciano Bruschi
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-09       Impact factor: 2.629

8.  Effect of highly active antiretroviral therapy on vaginal Candida spp. isolation in HIV-infected compared to HIV-uninfected women.

Authors:  Silvia de Souza Dantas Alczuk; Patrícia de Souza Bonfim-Mendonça; Sheila Cristina Rocha-Brischiliari; Cristiane Suemi Shinobu-Mesquita; Helen Priscilla Rodrigues Martins; Fabrícia Gimenes; André Luelsdorf Pimenta de Abreu; Maria Dalva de Barros Carvalho; Sandra Marisa Pelloso; Terezinha Inez Estivalet Svidzinski; Marcia Edilaine Lopes Consolaro
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

9.  Heparin-benzyl alcohol enhancement of biofilms formation and antifungal susceptibility of vaginal Candida species isolated from pregnant and nonpregnant Saudi women.

Authors:  Raid A Al-Akeel; Talat A El-Kersh; Yazeed A Al-Sheikh; Ziab Zakey Al-Ahmadey
Journal:  Bioinformation       Date:  2013-04-13

10.  Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR.

Authors:  Mahnaz Mahmoudi Rad; Ameneh Sh Zafarghandi; Maryam Amel Zabihi; Mahkam Tavallaee; Yasaman Mirdamadi
Journal:  Infect Dis Obstet Gynecol       Date:  2012-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.